What is Bipolar Depression?
Bipolar depression is diagnosed based on a history of mania or hypomania and the presence of a current major depressive episode. Symptoms can impair your functioning at work or school, your social and personal relationships, and other important aspects of your life.
ALTO-100-211 Study
The purpose of this research study is to compare the effects of ALTO-100, the study’s investigational drug, versus a placebo (an inactive substance) in treating symptoms of depression in participants who have bipolar disorder (BD) with depression (BD-D) and who are also taking mood stabilizers and/or an atypical antipsychotic.
The study will last approximately 3 to 4 months, consisting of a screening period followed by a treatment period where you may receive ALTO-100 or the placebo. Eligible participants will receive study-related care and evaluations at no cost. Compensation for your time and travel may be available.
Importantly, as a study participant you will remain under the care of your current doctor while also working with a team of research doctors and study staff who will monitor your overall health while participating in the trial.
Am I Eligible?
If you’re living with bipolar depression, you may be eligible for the ALTO-100-211 study.
The ALTO-100-211 study is looking for adults who:
• Are 18-70 years old
• Have an existing diagnosis of bipolar disorder with depression (BD-I or BD-II)
and are currently depressed
• At baseline, taking a mood stabilizer and/or one approved atypical antipsychotic for at least 6 weeks with no dose modifications in the past 2 weeks
• Are willing to comply with all study assessments and procedures
• Must not be pregnant or breastfeeding
If you meet these criteria, the ALTO-100-211 study may be of interest to you.
To learn more and see if you may be eligible, contact our team:
Email: [email protected]
Tel No: 01865 902135
